# FDA Inspection 1006673 - Sandoz Private Limited - March 03, 2017

Source: https://www.keypedia.com/records/fda_inspections/sandoz-private-limited/9229958d-9cf3-4090-8c3f-9c2ef06e0fcd
Source feed: FDA_Inspections

> FDA Inspection 1006673 for Sandoz Private Limited on March 03, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006673
- Company Name: Sandoz Private Limited
- Inspection Date: 2017-03-03
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1241485 - 2024-07-02](https://www.keypedia.com/records/fda_inspections/sandoz-private-limited/f48fa883-4346-4d4e-8406-a69f9bab284d)
- [FDA Inspection 1137294 - 2020-02-27](https://www.keypedia.com/records/fda_inspections/sandoz-private-limited/14fcb140-cf2e-4dba-98b6-fc8784e6fc39)
- [FDA Inspection 1086018 - 2019-04-12](https://www.keypedia.com/records/fda_inspections/sandoz-private-limited/c85bfef3-c96b-46ac-83e0-b3231aefa95a)
- [FDA Inspection 893384 - 2014-08-29](https://www.keypedia.com/records/fda_inspections/sandoz-private-limited/b7b406ad-0b61-49dc-8f52-771f2fd721e7)
- [FDA Inspection 775622 - 2012-03-16](https://www.keypedia.com/records/fda_inspections/sandoz-private-limited/58ae877c-e5d8-4063-bdc9-7d44b8bda6fb)

Company: https://www.keypedia.com/companies/sandoz-private-limited/951a0c7e-ffd5-45d2-bd94-f8e91f5e39a4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c